Rutgers Cancer Institute’s Post

The Watson McDaniel Company DL Series Dome-Loaded regulator uses air pressure to directly load the diaphragm to control downstream steam pressure. These valves are used for general steam distribution, as well as specific applications such as rubber molding lines and other steam process applications. An external sensing line connected between the valve diaphragm area and the outlet piping provides the feedback necessary for accurate pressure control. Downstream steam pressure is then easily controlled by adjusting the air pressure to the diaphragm. These valves share the design and proven reliability of the Watson McDaniel HD Series Regulators. The specially designed diaphragms allow for 100:1 flow rangeability. Just like the standard HD Series, body materials available are ductile iron, carbon steel and stainless steel. All styles have short lead times. Optional remote control panels are available with integrated pressure gauges and an air pressure regulator. Watsonmcdaniel.com Sales@watsonmcdaniel.com 610-495-5131 #steam #condensate #usamanufacturing #valves #mechanicalcontractor #piping #industrial

Meet ONCOVALUE researcher: Wim van Harten! He is a Senior Research Group Leader at The Netherlands Cancer Institute and Chair of the Working Group on Health Economics at the Organisation of European Cancer Institutes (OECI). Wim is excited to also serve as Co-Principal Investigator at The Netherlands Cancer Institute. In this role, he oversees two PhD candidates, concentrating on early-stage and dynamic technology assessment. His passion lies in collaborating with the ONCOVALUE Consortium to effectively mine and organize data, ensuring compliance with regulations. His goal? To provide valuable insights that enhance decision-making in oncology, ultimately improving patient outcomes and resource allocation. To know more about his research for ONCOVALUE, read more below. #ONCOVALUE #Consortium #data #oncology

A Great Research Collaboration Opportunity! 💥 (Edited) We need to write a review article on any Oncology Topic. I have been invited by the prestigious journal "Oncologie" for a review article. (IF= 1.4) If anyone wants to publish their review article in process or in between the process and can complete the project till 25th October 2024 then we can collaborate to work on that project. By review article I mean Scoping Review, Systematic Review, Systematic Review ± Meta-analysis, Narrative Review and Umbrella Review! All APC charges will be covered by me! Note: I will chose the best article for the submission because my DM is flooded with the requests hence please make sure you have quality article near to submission process! Keep following! keep researching! #publication #research #oncology

Dozens of our oncologists and researchers recently attended the American Society of Clinical Oncology (ASCO) conference. It’s the largest cancer conference in the world and an invaluable opportunity for us to learn about and share the latest therapies, research, and technology for our patients.  Big themes this year include: EQUITY in clinical trials, screening, and prevention. ADVOCACY to address patient challenges and transform care. ADVANCEMENTS in research to create better treatment options.  We’re incredibly proud of our team.  Learn more about just some of work we’re doing in these areas. Equity: https://bit.ly/3VcY9K1 Advocacy: https://bit.ly/45dI0IU Advancements: https://bit.ly/45boDQw

Top 10 Association of Cancer Center Administrators 2024 lessons. 10. Ted Yank once attended his first CCAF and his goal was to meet every administrator. 9. The word *liaison* is the new “more cow bell”. It shall appear on every page of future CCSG applications. 8. Philadelphia is really lucky to have those four center directors serving their community. Credit to Matthew Huesser, MBA, DBA for the strong Q&A. They should start a podcast. 7. Egg, cheese, and bacon can be baked within the center of the bagel, which is a stuffed Polish bread roll?! Delicious Kismet Bagels 6. Our center scored in the top 25% of PEDs reviewed to-date. Our goal should be top 10%. 5. Like UW Carbone Cancer Center, a handful of NCI centers are interviewing new directors. 4. More of my staff should be attending Association of Cancer Center Administrators conferences. The agendas are worth the travel. 3. How centers connect community outreach, education, and diversity efforts is still evolving, but a lot of smart people are innovating great ideas. 2.  Cancer centers are leading models for academic health systems. We foster sustainable symbiotic academic & clinical missions. 1. Data Table 3. I hardly knew you. But I already miss you. https://lnkd.in/gZwE7_Ty

The only peer-reviewed research journal dedicated to the advancement of artificial intelligence applications in clinical and precision oncology. In souvenir of Marie Curie and all the Women who contribute to the advancement of Life Science. Please subscribe to this unique publication. www.liebertpub.com/aipo - Karla Shepard Rubinger #ai #oncology #peerreview #oncologyresearch

In this article, CDP Consultant Biomedical Engineer María Fernández-Martos Balson delves into the latest progress in diagnostics, data analytics, cell biology, and delivery devices empowering oncology companies to extend the hope of longer, healthier lives to an even broader range of patients. Read the full article 👉 https://lnkd.in/eQbXRtit Let us know in the comments, what developments in the field of oncology are you most excited about? #Oncology #CancerResearch #MedicalInnovation #Healthcare #Science

And last but not least, Michele Jonsson Funk, Jennifer Lund (UNC Gillings School of Global Public Health, UNC Pharmacoepi, UNC Lineberger Comprehensive Cancer Center) and team begin a new Triangle CERSI project to tackle a well-known challenge with using external #comparatorgroups for #clinicaltrials, particularly in #oncology. An index date is the starting point for measuring outcomes. The timing of when to start tracking outcomes in the comparator group affects the estimated risks and can introduce biases. By using simulations and real-world examples, the research team aims to evaluate different index date selection strategies and their impact on bias and outcome estimation. The findings will inform FDA discussions, support regulatory decisions, and enhance the understanding of external comparator arm designs, particularly in complex settings like #rarediseases and oncology.   This project addresses charge 1 of the FDA’s regulatory science framework: Modernize development and evaluation of FDA-regulated products with a focus on methods to assess #realworlddata to serve as #realworldevidence. The Triangle CERSI is a Center of Excellence funded by the FDA to University of North Carolina at Chapel Hill and Duke University with partners, North Carolina Central University and North Carolina State University. To date, the Triangle CERSI has generated $11.1 million toward accelerating access to emerging scientific approaches essential for the FDA to remain at the forefront of regulatory decision making.